###begin article-title 0
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
Distinct proteins encoded by alternative transcripts of the PURG gene, located contrapodal to WRN on chromosome 8, determined by differential termination/polyadenylation
###end article-title 0
###begin p 1
###xml 213 217 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 222 225 218 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 834 840 810 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 911 917 875 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 962 968 926 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 1184 1190 1148 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 1206 1210 1170 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1317 1323 1281 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 1453 1459 1417 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 173 178 <span type="species:ncbi:9606">human</span>
A gene encoding a new member of the Pur protein family, Purgamma, has been detected upstream of, and contrapodal to, the gene encoding the Werner syndrome helicase, Wrn, at human chromosome band 8p11-12. Both the PURG and WRN genes initiate transcription at multiple sites, the major clusters of which are approximately90 bp apart. A segment containing this region strongly promotes transcription of a reporter gene in both directions. Both promoters are TATA-less and CAAT-less and both are positively regulated by Sp1 elements. While promoter elements for the two genes are interleaved, in the contrapodal direction, certain elements critical for each gene are distinct. Sequencing of cDNAs for Purgamma mRNA reveals that two alternative coding sequences are generated from a single gene, resulting in different Purgamma C-termini. PURG-A mRNA consists of a single intronless transcript of approximately3 kb. PURG-B mRNA results from transcription through the PURG-A polyadenylation site and splicing out of an intron of >30 kb. In this unique example of a switch, splicing of a single intron either occurs or does not occur depending upon differential termination/polyadenylation. PURG-B is the primary PURG transcript detected in testis, but it is undetectable in all members of a normal adult tissue cDNA panel. PURG-A levels are low or undetectable in the normal tissue panel, but they are greatly elevated in all members of a tumor tissue panel. PURG-B is detected in several tumor panel members.
###end p 1
###begin p 2
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
DDBJ/EMBL/GenBank accession nos+ To whom correspondence should be addressed. Tel: +1 212 241 7510; Fax: +1 212 534 7491; Email: edward.johnson@mssm.edu AF195513.2, AV077841, AF479672, AF479673
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c1">1</xref>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c4">4</xref>
###xml 302 303 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c1">1</xref>
###xml 598 599 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c2">2</xref>
###xml 954 955 926 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c5">5</xref>
###xml 1062 1063 1030 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c6">6</xref>
###xml 1236 1237 1200 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c7">7</xref>
###xml 1346 1347 1306 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c8">8</xref>
###xml 1348 1350 1308 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c12">12</xref>
###xml 1527 1529 1480 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c13">13</xref>
###xml 1590 1592 1540 1542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c14">14</xref>
###xml 1700 1701 1646 1647 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1706 1707 1652 1653 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1721 1723 1667 1669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c15">15</xref>
###xml 1724 1726 1670 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c16">16</xref>
###xml 1759 1763 1705 1709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURA</italic>
###xml 1768 1772 1714 1718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURB</italic>
###xml 1836 1838 1782 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c14">14</xref>
###xml 1845 1848 1791 1794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUR</italic>
###xml 1975 1985 1921 1931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 464 469 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 505 510 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 663 668 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 779 787 <span type="species:ncbi:10632">JC virus</span>
###xml 789 792 <span type="species:ncbi:10632">JCV</span>
###xml 925 928 <span type="species:ncbi:10632">JCV</span>
###xml 961 966 <span type="species:ncbi:10090">mouse</span>
###xml 1152 1157 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1162 1167 <span type="species:ncbi:9606">human</span>
###xml 1221 1226 <span type="species:ncbi:10090">mouse</span>
###xml 1548 1553 <span type="species:ncbi:9606">human</span>
###xml 1898 1904 <span type="species:ncbi:9606">humans</span>
###xml 1918 1923 <span type="species:ncbi:9606">human</span>
###xml 1975 1985 <span type="species:ncbi:7227">Drosophila</span>
Pur family members are multifunctional proteins reported to function in both DNA and RNA metabolism (1-4). Pur family members studied thus far are sequence-specific single-stranded DNA- and RNA-binding proteins. The ability of Puralpha, the first family member cloned (GenBank accession no. NM005859) (1), to regulate viral DNA transcription and replication in mammalian cells may provide a model for its cellular roles. Puralpha binds the protein Tat, encoded by HIV-1, and enhances transcription of the HIV-1 genome in a manner dependent on Puralpha also binding to the resulting RNA transcript (2). Puralpha binds to the TAR RNA element near the 5'-end of the HIV-1 transcript and to Tat, which binds TAR near the Puralpha-binding site. Puralpha binds to a similar element in JC virus (JCV) DNA in the viral replication/transcription regulatory region and Puralpha and Tat act synergistically at this element to stimulate JCV late gene transcription (5). In mouse cells Puralpha stimulates transcription of the BC1 gene and binds to the resulting transcript (6), providing another example of a DNA- and RNA-binding pattern similar to that seen with HIV-1. In human cells Puralpha binds to 7SL RNA, which is related to mouse BC1 RNA (7). Puralpha has now been implicated in transcriptional regulation of a variety of additional cellular genes (8-12). Puralpha has been reported to associate with another Pur family member, Purbeta, the resulting complex being involved in regulation of the vascular smooth muscle actin gene (13). The sequence of human Purbeta cDNA has now been reported (14) (GenBank accession no. AY039216). Increased levels of Puralpha protein inhibit cell cycle progression at G1 or G2 checkpoints (15,16). Simultaneous deletions of the PURA and PURB genes occur at a high frequency in acute myelogenous leukemia (14). The PUR gene family is strongly conserved from plants to humans. Whereas the human genome contains at least three family members, the Drosophila genome contains only one (GenBank accession no. AF021259).
###end p 4
###begin p 5
###xml 340 343 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUR</italic>
###xml 365 367 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c17">17</xref>
###xml 597 599 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c18">18</xref>
###xml 716 719 704 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 901 905 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 929 932 913 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 991 995 975 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1039 1043 1023 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1049 1051 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c19">19</xref>
###xml 1052 1054 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c20">20</xref>
###xml 1075 1079 1059 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1122 1125 1106 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 122 127 <span type="species:ncbi:9606">human</span>
###xml 149 154 <span type="species:ncbi:4932">yeast</span>
###xml 660 665 <span type="species:ncbi:9606">human</span>
Each Pur family member contains three class I amino acid repeats which are highly conserved and are related to repeats in human Myb proteins and the yeast protein Rap1. All Pur proteins also contain two class II repeats separating the class I repeats. The class I repeats in Puralpha are crucial for its ability to bind its single-stranded PUR recognition element (17). To identify new members of the Pur family of proteins, a short Puralpha sequence corresponding to the class I repeat was used to screen for homologous DNA sequences registered in the GenBank database using the tBLASTn program (18). A significant Puralpha homolog was found to be present in human genomic DNA upstream of the Werner syndrome gene, WRN. This sequence comprised a complete open reading frame (ORF) for a characteristic Pur protein, which we have designated in the present report as Purgamma. The gene is designated as PURG. In characterizing the WRN promoter, investigators had previously deleted regions of PURG, but they did not note the presence of the PURG ORF (19,20). Intriguingly, the PURG ORF is in the opposite orientation to the WRN ORF.
###end p 5
###begin p 6
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c21">21</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c23">23</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c22">22</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c23">23</xref>
###xml 352 355 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 505 521 505 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c24">24</xref>
###xml 597 602 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RecQL</italic>
###xml 604 607 604 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 609 612 609 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RecQ4</italic>
###xml 624 629 624 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RecQ5</italic>
###xml 670 673 670 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 675 678 675 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BLM</italic>
###xml 683 688 683 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RecQ4</italic>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c25">25</xref>
###xml 865 868 865 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c25">25</xref>
###xml 940 943 940 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
###xml 223 230 <span type="species:ncbi:36185">graying</span>
###xml 505 521 <span type="species:ncbi:562">Escherichia coli</span>
###xml 560 565 <span type="species:ncbi:9606">human</span>
###xml 989 997 <span type="species:ncbi:9606">patients</span>
Werner syndrome is a rare autosomal recessive disorder causing several characteristics of premature aging and certain types of cancers (21-23). Werner syndrome patients are prone to juvenile cataracts, atrophy of the skin, graying and loss of hair, diabetes, arteriosclerosis, osteoporosis and neoplasia characterized by multiple sarcomas (22,23). The WRN gene is located at chromosome band 8p11-12 and encodes a protein of 1432 amino acids with significant homology in its helicase domain to that of the Escherichia coli RecQ DNA helicase (24). To date, five human RecQ-type helicase genes, i.e. RecQL, WRN, BLM, RecQ4 and RecQ5, have been identified. Mutations in the WRN, BLM and RecQ4 genes have been shown to be responsible for the autosomal disorders known as Werner syndrome, Bloom syndrome and Rothmund-Thomson sydrome, respectively (25). Most mutations in WRN affect helicase activity (25). The mechanism by which mutations in the WRN gene cause the phenotypes in Werner syndrome patients remains unknown.
###end p 6
###begin p 7
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 411 415 411 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
The head-to-head orientation of WRN and PURG raises the question of whether the two genes could share promoter sequences and whether their expression could be co-regulated. Therefore, we have sought here to define the PURG transcription unit and to characterize its promoter, the structure of the gene and its expression. Surprisingly, we have found unique aspects of both the initiation and termination of the PURG gene. A novel termination/polyadenylation switch allows the gene to encode either of two proteins, with different C-termini.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
Cell culture
###end title 9
###begin p 10
###xml 70 71 70 71 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 230 231 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 156 162 <span type="species:ncbi:9913">bovine</span>
HeLa cells were maintained in Dulbecco's modified Eagle's medium with l-glutamine and 4.5 g/l glucose (Cellgro Mediatech) supplemented with 10% (v/v) fetal bovine serum (Gibco BRL) at 37degreesC in a humidified atmosphere of 5% CO2, 95% air.
###end p 10
###begin title 11
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 31 36 <span type="species:ncbi:9606">human</span>
Two-step RT-PCR and 5'-RACE of human testis PURG mRNA
###end title 11
###begin p 12
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C.therm.</italic>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c26">26</xref>
###xml 484 488 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 509 517 509 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C.therm.</italic>
###xml 864 868 864 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 941 945 941 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1154 1157 1154 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 1180 1183 1180 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 1189 1192 1189 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 435 440 <span type="species:ncbi:9606">Human</span>
###xml 1207 1210 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Human testis mRNA (Clontech) was reverse transcribed with C.therm. Polymerase (Roche Molecular Biochemicals) and the products were purified with a Qiagen PCR purification kit. PCR was done with an Expand High-Fidelity PCR System (Roche) including 1.5 M betaine and 5% DMSO. Performance of 5'-RACE (rapid amplification of cDNA ends) (26) was carried out according to the kit manufacturer's instructions (Roche) with some modifications. Human testis mRNA was reverse transcribed with a PURG-specific primer and C.therm. Polymerase and the products treated with RNase H before being purified with a Qiagen PCR purification kit. The single-stranded cDNA was then tailed at its 3'-end, corresponding to the 5'-end of the original mRNA, with dATP and terminal deoxynucleotide transferase. The cDNA was then amplified, first using an oligo(dT) anchor primer and a nested PURG-specific primer and second using the anchor primer and a further nested PURG-specific primer. The second PCR products were phosphorylated at their 5'-ends with polynucleotide kinase, and the ends completed with the Klenow fragment of DNA polymerase I. Products were then digested with SalI and ligated into the SalI and SmaI sites of pBK-CMV (Stratagene). Sequencing was carried out by the DNA Sequencing Core Facility at the Mount Sinai School of Medicine.
###end p 12
###begin title 13
PCR primer sequences employed
###end title 13
###begin p 14
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f1">1</xref>
The following sequences were employed as primers for PCR amplification for 5'-RACE or for amplification of either the PURG-A or PURG-B cDNAs in expression panels. Numbering is relative to the WRN +1 site as shown in Figure 1. R1 (-1110, -1085), 5'-CTACTCTTGCTTAGGCCAGAGCCCCC-3'; R2 (-390, -366), 5'-GAGGGGGTCTCCGCTCTTCCTCAGT-3'; R3 (-363, -339), 5'-ACTCTCTGACTGAAGCCCGGCGCGT-3'; R4 (-325, -304), 5'-AGTGCGAGGGGACTGGACAGGT-3'; F1 (-905, -925), 5'-GGGCCCGGCGTGGGGGTCGCG-3; F2 (-716, -740), 5'-ATGGCAGAGATGATGTGAGTGCCCG-3'; F3 (-562, -583), 5'-CGATGCCCCTGCCCGGCTGCTC-3'; F4 (-411, -431), 5'-CGGGGGAGGCGGGGTCCACCG-3'; F5 (-261, -285), 5'-AGTGAGAACATTCCCGCCGCCCGGT-3'; F6 (-176, -199), 5'-CTGCCGCTGAGCACCTCGGGAAGT-3'; F7 (+3, -20), 5'-ATCAGCTCCGGGAGACCTACCCG-3'; F8 (+257, +233), 5'-GCCTAAGCGCCTCCACGTGTCTCAG-3'; HPC5, 5'-ATGGAAAGAGCCAGGCGAAGGG-3'; HPC5M, 5'-GTGATGCCTTGGTTCAGCTG-3'; HPCA3, 5'-CTAGTCGAGGCATTCTTGTTC-3'; HPCB3, 5'-GAGGCCTTGCATTCATGATGAAC-3'. HPC5 is at the 5'-end of the Purgamma coding sequence. HPC5M is internal in the shared region of both Purgamma-A and Purgamma-B. HPCA3 is at the 3'-end of the Purgamma-A coding sequence. HPCB3 is in the 3'-untranslated region (UTR) of Purgamma-B mRNA.
###end p 14
###begin title 15
PGL3 constructs for luciferase assays
###end title 15
###begin p 16
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 273 276 273 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 284 287 284 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 412 415 412 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 421 424 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 449 452 449 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
Plasmid pGL3-Basic is a luciferase reporter vector with no promoter upstream of the firefly luciferase gene (Promega). DNA fragments of different size in the PURG promoter region were obtained by PCR using the Expand High-Fidelity System (Roche) and appropriate primers. A XhoI and a HindIII restriction site were added to the upstream primer and downstream primer, respectively. PCR products were digested with XhoI and HindIII and cloned into the XhoI and HindIII sites of pGL3-Basic. Insert sequences in all pGL3 constructs were verified at the Mount Sinai School of Medicine DNA Sequencing Core Facility.
###end p 16
###begin title 17
Transient transfections and luciferase assays
###end title 17
###begin p 18
Monolayers of HeLa cells were allowed to reach 50-80% confluence 16-20 h before transfection. Each well of a 6-well plate was transfected with an equimolar amount of each of the different pGL3 constructs and 0.3 microg pSV-beta-galactosidase control vector (Promega) using the FuGene6 transfection reagent (Roche) according to the manufacturer's instructions. After 48 h, cells in each well were lysed in 150 microl of Reporter Lysis Buffer and stored at -70degreesC. An aliquot of 20 microl was assayed for luciferase activity and an aliquot of 70 microl was assayed for beta-galactosidase activity as recommended (Promega). Light emissions in luciferase assays were determined with a Top Count NXT Microscintillation and Luminescence Counter (Packard Instrument Co.). All measurements were in the linear range of detection. Transfection for each pGL3 construct was performed at least twice. The luciferase activities of pGL3 constructs were normalized for differences in transfection efficiencies using the beta-galactosidase activity. Luciferase activities were expressed as fold stimulation above the activity observed for pGL3-Basic, the parental vector for the different pGL3 constructs.
###end p 18
###begin title 19
RESULTS
###end title 19
###begin title 20
Head-to-head orientation of genes encoding a new Pur family member, Purgamma, and the Werner syndrome helicase, Wrn, at chromosome band 8p11-12
###end title 20
###begin p 21
###xml 251 254 243 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 395 398 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 418 419 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f1">1</xref>
###xml 455 458 447 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 482 487 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 490 492 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c19">19</xref>
###xml 823 830 804 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1436 1439 1417 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 1481 1482 1462 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f1">1</xref>
###xml 1677 1681 1658 1662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1710 1713 1691 1694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 1857 1858 1834 1835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f1">1</xref>
###xml 1862 1868 1839 1845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 1897 1903 1874 1880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 2011 2014 1988 1991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 2019 2023 1996 2000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 2145 2146 2122 2123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f1">1</xref>
###xml 2237 2241 2214 2218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 584 589 <span type="species:ncbi:9606">human</span>
###xml 919 924 <span type="species:ncbi:9606">human</span>
By searching for homologous DNA sequences in the GenBank database with a Puralpha amino acid sequence comprising a class I repeat using the tBLASTn program, we have discovered a Puralpha homolog within the promoter region of the Werner syndrome gene, WRN. This sequence contains an ORF of 1044 bp which is located between 1025 and 2068 bp upstream of the most 5' transcription start site of the WRN gene, WRN +1 (Fig. 1). Numbering for this region of the WRN gene is that of Yamabe et al. (19). The new ORF encodes a peptide sequence of 347 amino acids which has high homology to the human Puralpha and Purbeta protein sequences. Especially high homology is observed in regions corresponding to the three class I repeats, two class II repeats and the 'psycho' motif of Puralpha. To find out whether this ORF is transcribed in vivo, we performed a tBLASTn search of its amino acid sequence against the dbEST database. A human cDNA clone from pooled libraries of fetal lung, testis and B cells was identified. The 106 bp sequence tag of that cDNA clone is exactly the same as a part of the ORF. That cDNA clone, designated here pHPURG1, was obtained from the American Type Culture Collection and the entire insert of 1925 bp was sequenced. The insert sequence goes from codon 14 to the stop codon of the ORF, followed by an 897 bp 3'-UTR and a poly(A) tail. It corresponds to the genomic sequence between 1064 and 2966 bp upstream of the WRN transcriptional start site, WRN +1 (Fig. 1). Thus, pHPURG1 contains an incomplete protein coding sequence and an intact 3'-UTR. These data, together with data obtained from the following experiments, indicate that a new Pur family gene, PURG, is located upstream of the WRN gene. Because, as described later in this paper, there exists another isoform of Purgamma, we designate the transcription unit shown in Figure 1 as PURG-A. Sequencing of the complete PURG-A cDNA (GenBank accession no. AF195513) is described later in this paper after identification of the 5'-UTR. WRN and PURG are organized in a head-to-head configuration, such that they are transcribed in opposite directions, as shown in Figure 1. Contemplation of this figure raises two immediate questions. Where does transcription of PURG initiate? Do the two genes share essential promoter elements? We set out to answer these questions.
###end p 21
###begin title 22
5'-RACE identifies a long 5'-UTR of Purgamma mRNA with multiple transcriptional start sites
###end title 22
###begin p 23
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 595 599 591 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 629 637 625 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C.therm.</italic>
###xml 1086 1087 1068 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 1176 1177 1158 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 1313 1314 1295 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 1490 1491 1472 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 1777 1778 1755 1756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 1800 1804 1778 1782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1891 1894 1869 1872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 1906 1907 1884 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 2050 2054 2028 2032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 2179 2183 2157 2161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 2482 2486 2460 2464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 837 842 <span type="species:ncbi:9606">human</span>
###xml 2173 2178 <span type="species:ncbi:9606">human</span>
We noticed that the G+C content of the upstream DNA sequence of PURG, i.e. the sequence between WRN +1 and -1025, is high (76%, Fig. 2A). In particular, that of a 202 bp region, encompassing sites -755 and -956, is extremely high (89%, Fig. 2A). No specific products were obtained in an initial 5'-RACE experiment using nested PURG reverse primers downstream of the 202 bp region. If the 5'-end of Purgamma mRNA is located upstream of this region, we could perform 5'-RACE using reverse primers that are located upstream of this region. We thus employed RT-PCR to roughly define the position of PURG transcription start site(s). C.therm. Polymerase was used as the reverse transcriptase in the RT step because it functions well at temperatures as high as 70degreesC, enabling successful synthesis of cDNA from G+C-rich mRNA templates. A human testis mRNA preparation (Clontech) was chosen for both RT-PCR and 5'-RACE because it was determined to contain Purgamma mRNA. A reverse primer located downstream of, but near to, the 5'-end of the Purgamma coding sequence in pHPURG1 (R1, Fig. 2A) was used in reverse transcription and R1 and each of the forward primers (F1-F5, Fig. 2A) were used in PCR. PCR with R1 and F5 yields a single 850 bp product, exactly the size of genomic DNA located between R1 and F5 (Fig. 2B, left), a result deemed surprising since it indicated a long 5'-UTR. This product was not seen in the negative control in which the RT step had an incubation time of 0 (Fig. 2B, left). These data indicate that the 5'-end of Purgamma mRNA is located upstream of the position of the primer F5 and that there is no intron between F5 and R1. RT-PCR with reverse primer R3, located downstream of F5, and one forward primer located upstream of F5 (F6, F7 or F8, Fig. 2A) revealed that some PURG transcripts start from sites located upstream of primer F8, well into intron 1 of the WRN gene (Fig. 2B, right). There was a sharp decrease in band intensity when F7, instead of F6, was used together with R3 in the RT-PCR, suggesting that major PURG transcripts start from sites between F6 and F7 while minor transcripts start from sites further upstream. Thus, while human PURG might have more than one promoter, it is likely that one promoter governs the vast bulk of transcripts. The size of each of these PCR products is equal to that of the genomic DNA between each pair of the primers used in the PCR (data not shown), indicating that there is no intron in the 5'-end of PURG up to the position of F8.
###end p 23
###begin p 24
###xml 27 29 27 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c26">26</xref>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 160 168 160 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C.therm.</italic>
###xml 391 392 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 1411 1412 1371 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 1888 1890 1824 1826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c27">27</xref>
###xml 200 203 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 730 733 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
We then performed 5'-RACE (26) using nested PURG reverse primers R2, R3 and R4, which are located downstream of F5 but upstream of the 202 bp region (Fig. 2A). C.therm. Polymerase was used instead of AMV reverse transcriptase in the 5'-RACE kit (Roche) to ensure complete synthesis of first-strand cDNA from G+C-rich Purgamma mRNA. The second PCR products in the 5'-RACE are shown in Figure 2C. The size of major PCR products ranged from approximately188 to approximately318 bp, while some minor PCR products were >318 bp. These different sized products were specifically derived from Purgamma mRNAs with different transcription start sites, as confirmed by cloning and sequencing of these products. They were cloned into the pBK-CMV plasmid (Stratagene). Twenty clones containing inserts were selected, out of which eight were sequenced, including the two clones with the longest and shortest inserts. The inserts in all the eight clones were derived from Purgamma. They share the same 3'-end, i.e. the end of reverse primer R4, but have different 5'-ends, i.e. -92, -104, -119, -122, -130, -158, -185 and -193 with respect to WRN +1. The 5'-RACE results indicated that Purgamma was transcribed primarily from a cluster of initiation sites roughly between -92 and -193 with respect to WRN +1, and much less frequently from further upstream positions. This is consistent with the RT-PCR results shown in Figure 2B, in which the data suggest that Purgamma starts transcription mainly from sites located between F7 and F6, i.e. between +3 and -176 with respect to WRN +1, and less frequently from further upstream sites. Analysis of the mRNA sequence upstream of the 1044 bp ORF indicates that this ORF represents the complete Purgamma coding sequence. The median Purgamma mRNA 5'-UTR identified here is approximately900 bp in length. Such a long 5'-UTR is uncommon among eukaryotic mRNAs (27).
###end p 24
###begin title 25
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 73 76 73 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
Characterization of the PURG promoter reveals limited co-regulation with WRN
###end title 25
###begin p 26
###xml 25 26 25 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f3">3</xref>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 302 304 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c20">20</xref>
###xml 311 314 299 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 350 352 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c19">19</xref>
###xml 353 355 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c20">20</xref>
###xml 451 454 439 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 526 528 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c20">20</xref>
###xml 647 650 635 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 672 674 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c19">19</xref>
###xml 787 788 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f3">3</xref>
###xml 852 855 840 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 972 976 960 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1017 1021 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1048 1051 1036 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1092 1095 1080 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 1150 1154 1138 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1309 1312 1297 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 1323 1325 1311 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c19">19</xref>
###xml 1399 1403 1387 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1758 1759 1746 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f3">3</xref>
###xml 2096 2099 2060 2063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 2133 2135 2097 2099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c19">19</xref>
###xml 2326 2328 2290 2292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c28">28</xref>
###xml 2525 2528 2489 2492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 2586 2590 2550 2554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 2678 2679 2642 2643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f3">3</xref>
###xml 2739 2740 2691 2692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f3">3</xref>
###xml 2796 2800 2748 2752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 2989 2990 2941 2942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f3">3</xref>
###xml 3248 3249 3200 3201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f3">3</xref>
###xml 3339 3340 3291 3292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f3">3</xref>
###xml 3391 3394 3343 3346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUR</italic>
###xml 3501 3504 3449 3452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 3587 3589 3531 3533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c29">29</xref>
###xml 3628 3631 3572 3575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 3760 3763 3704 3707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUR</italic>
###xml 4042 4043 3982 3983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f3">3</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 1011 1016 <span type="species:ncbi:9606">human</span>
As illustrated in Figure 3A, the human PURG and WRN genes are organized such that their major clusters of transcription start sites are separated by approximately90 bp. Their minor transcription start sites are located upstream of their major transcription start sites, well into the contraposed gene (20). The WRN gene reportedly has two promoters (19,20). Luciferase reporter assays performed in several cell lines revealed that the activity of the WRN downstream promoter was 2-10-fold stronger than its upstream promoter (20). The region encompassing positions -67 and +160 was shown to be the minimal region required for full activity of the WRN downstream promoter (19). These investigators have demonstrated that two Sp1 elements (Sp1-1 and Sp1-2) and one RCE motif (RCE-1) (Fig. 3A) in the 67 bp region upstream of WRN +1 are indispensable for WRN downstream promoter activity. This short region also lies proximal to the downstream transcriptional start sites of PURG. In order to find out whether the human PURG transcription unit shares cis-acting regulatory elements with that of WRN, we performed 5' progressive deletion analyses of the PURG downstream promoter in luciferase reporter assays in HeLa cells. These cells were chosen because they had previously been used in characterization of the WRN promoter (19). A series of luciferase reporter constructs were generated by inserting PURG upstream sequences with progressively deleted 5'-ends into the pGL3-Basic vector (Promega). These constructs were transiently transfected into HeLa cells and the relative promoter activities of the various inserts were assessed by comparing the luciferase activities of these constructs with that of the parental vector pGL3-Basic. As revealed in Figure 3B, the DNA fragment from +166 to -363 with respect to WRN +1 had a strong promoter activity, approximately36% of the promoter activity of the same DNA fragment in the reverse direction. Deletion of 175 bp from the 5'-end (from +166 to -9) reduced promoter activity by approximately60%. This same region was also shown to be required for WRN promoter activity in HeLa cells (19). Thus this region is important for the transcriptional regulation of both genes. Scanning of this region using MatInspector, a program that searches for transcription factor-binding sites (28), did not reveal any clearly relevant candidates for regulatory elements. Further deletions of Sp1-1 (from -9 to -33), Sp1-2 (from -33 to -51) and RCE-1 (from -51 to -67), which play key roles in WRN transcription initiation, had no remarkable influence on PURG promoter activity. Truncation from -67 to -86 removed another Sp1 element, Sp1-3 (Fig. 3A), and reduced promoter activity by approximately50% (Fig. 3B). Sp1-3 may thus have a positive modulating effect on PURG transcription initiation. Further truncation to -113 had little effect on promoter activity, although several transcription start sites and a potential E2F-binding site were removed (Fig. 3). The removal of another 40 bp (from -113 to -153) only slightly reduced the promoter activity, leaving significant remaining promoter activity. This deletion removes several other transcription start sites and two potential elements, RCE-2 and Sp1-4 (Fig. 3). Little promoter activity remained when the deletions progressed to position -181 (Fig. 3B). The region between -153 and -181 contains five PUR elements of the form GNGG or GGNG. It is quite conceivable that Purgamma could autoregulate its gene, and WRN as well, since Puralpha has recently been shown to autoregulate its own promoter (29). This region contains no other known cis-regulatory elements, as revealed by MatInspector. It is notable that the region encompassing +52 to -153 also contains multiple PUR elements. The DNA fragment from positions +167 to -1024, the beginning of the Purgamma coding sequence, had a promoter activity 20% that of the DNA fragment from +166 to -363, suggesting that there are negative regulatory elements in the long 5'-UTR between -363 to -1024 (Fig. 3B).
###end p 26
###begin title 27
###xml 53 57 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
Two isoforms of Purgamma mRNA are expressed from the PURG gene
###end title 27
###begin p 28
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURA</italic>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURB</italic>
###xml 1370 1377 1339 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hPURG-A</italic>
###xml 1483 1490 1448 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mPURG-B</italic>
###xml 1708 1712 1669 1673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 412 417 <span type="species:ncbi:9606">human</span>
###xml 477 482 <span type="species:ncbi:10090">mouse</span>
###xml 547 552 <span type="species:ncbi:10090">mouse</span>
###xml 827 832 <span type="species:ncbi:9606">human</span>
###xml 1037 1042 <span type="species:ncbi:9606">human</span>
###xml 1098 1103 <span type="species:ncbi:9606">human</span>
###xml 1339 1344 <span type="species:ncbi:9606">human</span>
###xml 1452 1457 <span type="species:ncbi:10090">mouse</span>
###xml 1726 1731 <span type="species:ncbi:9606">human</span>
###xml 1736 1741 <span type="species:ncbi:10090">mouse</span>
Results presented thus far indicate that the major transcripts of human PURG-A possess a coding region of 1044 bp, a 5'-UTR as long as 1282 bp and an intact 3'-UTR of 897 bp (GenBank accession no. AF195513). The entire sequence of PURG-A contains no intron, as is also true of PURA and PURB. The 347 amino acid Purgamma protein is highly homologous to Puralpha and Purbeta. Searching the dbEST database with the human Purgamma coding sequence using the BLAST program yielded a mouse blastocyst cDNA clone, designated here pMPURG1. We obtained the mouse clone and sequenced the entire insert. The insert in pMPURG1 begins with an ORF of 293 codons, followed by an intact 3'-UTR of 806 bp and concludes with a poly(A) tail. The first 258 codon sequence in pMPURG1 is 93% identical to the 258 codon sequence from 31 to 288 in the human Purgamma cDNA, while their amino acid sequences are 97% identical. Yet the 35 codons from 259 to 292 and the 3'-UTR in pMPURG1 are completely different to the sequence from codon 289 to the 3'-end in the human Purgamma cDNA. The genomic sequence after codon 288 of human Purgamma is GTAAGT, matching the consensus sequence for a 5' splice site of introns in higher eukaryotes. Based on these observations, we hypothesized that an intron located after codon 288 was not spliced out from the precusor RNA of human Purgamma, which we named hPURG-A, but that a corresponding intron was spliced out from the precusor RNA of mouse Purgamma, which we named mPURG-B, the sequence of which is now available (GenBank accession no. AF479672). We shall present evidence that this hypothesis is correct and that the two isoforms of Purgamma mRNA are expressed alternatively from a single PURG gene in both human and mouse.
###end p 28
###begin p 29
###xml 864 871 836 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mPURG-A</italic>
###xml 1461 1465 1413 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 209 214 <span type="species:ncbi:10090">mouse</span>
###xml 280 285 <span type="species:ncbi:9606">human</span>
###xml 551 556 <span type="species:ncbi:10090">mouse</span>
###xml 1455 1460 <span type="species:ncbi:10090">mouse</span>
Human primers HPC5 and HPCA3, corresponding to the 5'- and 3'-ends, respectively, of the 1044 bp hPurgamma-A coding sequence, were used to amplify potential mouse Purgamma-A (mPurgamma-A) coding sequence from mouse genomic DNA. A single product with a size similar to the 1044 bp human DNA was obtained. Sequencing revealed that it was 1053 bp long and 94% identical to the 1044 bp hPurgamma-A coding sequence. The protein thus encoded would be 350 amino acids long and 97% identical to the 347 amino acid hPurgamma-A protein. A cDNA clone from adult mouse testis has subsequently been identified that contains the 1053 bp PCR product sequence plus an 11 bp 5'-UTR and a 139 bp 3'-UTR, all of which are highly homologous to corresponding regions in hPurgamma-A cDNA. Thus this clone contains a partial cDNA sequence of mPurgamma-A. The complete coding sequence of mPURG-A is now available (GenBank accession no. AF479673). While the first 258 codons of mPurgamma-B in pMPURG1 are identical to codons 34-291 in mPurgamma-A cDNA, the codons C-terminal to these are different. Since there is no intron in the 1053 bp mPurgamma-A coding sequence, there must be an intron located between codons 258 and 259 of mPurgamma-B in pMPURG1. In agreement with this conclusion, the genomic sequence after codon 258 is GTAAGT, the typical 5' splice site of introns in higher eukaryotes. It is thus evident that two different Purgamma mRNAs are transcribed from a single mouse PURG gene.
###end p 29
###begin p 30
###xml 635 636 615 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f4">4</xref>
###xml 994 1001 962 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hPURG-B</italic>
###xml 1405 1409 1365 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1469 1470 1429 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f5">5</xref>
###xml 1777 1781 1733 1737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 142 147 <span type="species:ncbi:9606">human</span>
###xml 366 371 <span type="species:ncbi:9606">human</span>
###xml 426 431 <span type="species:ncbi:9606">human</span>
###xml 1290 1295 <span type="species:ncbi:9606">human</span>
###xml 1445 1450 <span type="species:ncbi:9606">human</span>
###xml 1455 1460 <span type="species:ncbi:10090">mouse</span>
###xml 1517 1522 <span type="species:ncbi:9606">human</span>
###xml 1527 1532 <span type="species:ncbi:10090">mouse</span>
By searching the dbEST database with the exon 2 sequence of mPurgamma-B with the BLAST program, we identified and sequenced a cDNA clone from human fetal lung (GenBank accession no. AI338787). It contains an insert of 789 bp, followed by a poly(A) tail. Since the insert is 82% identical to the 806 bp mPurgamma-B 3'-UTR, we surmised that it is the intact 3'-UTR of human Purgamma-B (hPurgamma-B). RT-PCR amplification from a human testis mRNA preparation (Clontech) with reverse primer HPCB3, derived from the 789 bp insert sequence, in the RT step and HPCB3 and HPC5 in the PCR step indeed generated a partial hPurgamma-B cDNA (Fig. 4). As expected, this hPurgamma-B cDNA shares only the first 288 codon sequence of hPurgamma-A. The following 35 codon sequence encodes 34 amino acids that are 91% identical to the 34 amino acids encoded by exon 2 of mPurgamma-B mRNA. The remaining partial 3'-UTR sequence is the same as that of the 789 bp insert initially obtained. The complete sequence of hPURG-B cDNA is now available (GenBank accession no. AV077841). As in mPurgamma-B, there is an intron located between codons 288 and 289 of hPurgamma-B. There is no other intron after codon 289 because the cDNA sequence is identical to the genomic sequence from nucleotides 16737 to 17629 in the human BAC clone RP11-293D9 (GenBank accession no. AC008066). In summary, the genomic structure and DNA sequence of PURG genes are highly conserved between human and mouse. Figure 5 presents a comparison of the C-termini of the human and mouse Purgamma-A and -B isoforms. The position of the apparently spliced-out intron in the mRNAs encoding the B isoforms is indicated by dashed lines. To shed further light on how these isoforms are generated it was necessary to examine chromosome 8 PURG genomic DNA.
###end p 30
###begin title 31
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
Diffferential termination/polyadenylation accounts for two different PURG mRNAs encoding distinct protein isoforms
###end title 31
###begin p 32
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hPURG-B</italic>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 422 429 422 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hPURG-B</italic>
###xml 776 783 772 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hPURG-A</italic>
###xml 845 852 841 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hPURG-B</italic>
###xml 878 879 874 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f6">6</xref>
###xml 927 931 923 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 939 945 935 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 950 956 946 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 995 996 991 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1018 1024 1014 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 1029 1035 1025 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 1181 1187 1177 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 1192 1194 1188 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-B</italic>
###xml 1209 1213 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1278 1284 1274 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 1318 1324 1314 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 1447 1451 1443 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1512 1518 1508 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 1983 1987 1979 1983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 503 508 <span type="species:ncbi:9606">Human</span>
###xml 913 918 <span type="species:ncbi:9606">human</span>
The human chromosome 8 BAC clone RP11-293D9 contains a 16736 bp partial intron sequence which is located upstream of exon 2 of hPURG-B. The sequence at the 3'-end of the intron is TTTTTTCTTTAG, matching the consensus sequence for the 3' splice site of introns in higher eukaryotes. The genomic sequence upstream of WRN (GenBank accession no. AF181896) contains exon 1 and the following 12427 bp partial intron sequence of hPURG-B. It does not overlap the 16736 bp partial intron sequence in RP11-293D9. Human chromosome 8 BAC clone RP11-473A17 (GenBank accession no. AC084736) overlaps these two clones of the intron, but there are unsequenced regions between them. Together these data indicate that exon 2, encoding the hPurgamma-B C-terminus, does in fact lie downstream of hPURG-A on chromosome 8. The data also indicate that the size of the hPURG-B intron is >30 kb. Figure 6 illustrates the structure of the human genomic PURG locus. PURG-A and PURG-B cDNAs were both generated from poly(A)+ mRNA molecules. Thus PURG-A and PURG-B polyadenylation sites are located >30 kb apart on genomic DNA. The only plausible mechanism that can explain the transcription and processing of PURG-A and -B mRNAs is that PURG transcription terminates at two different regions, one near the PURG-A poly(A) site, the other near the PURG-B poly(A) site. One alternative mechanism is extremely unlikely but not presently completely ruled out. It would posit that PURG transcription terminates at only one region, i.e. 3' to the PURG-B poly(A) site. Cleavage and polyadenylation would then occur either near the 3'-terminus or, alternatively, >30 kb upstream of the terminus. Such cleavage is unprecedented and no mechanism thus far elucidated can account for cleavage and polyadenylation so far upstream of transcriptional termination. This is further considered in the Discussion. There are several instances of possible alternative termination in the literature. Nonetheless, transcription of the PURG gene is unique in that it is the only reported instance in which splicing of a single intron either does or does not occur, depending on differential termination/polyadenylation, resulting in different protein C-termini.
###end p 32
###begin title 33
Differences in Purgamma-A and Purgamma-B mRNA expression in various organs and tumor cell lines
###end title 33
###begin p 34
###xml 194 195 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f4">4</xref>
###xml 417 418 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f4">4</xref>
###xml 251 256 <span type="species:ncbi:9606">human</span>
RT-PCR with reverse primer HPCA3 in the RT step and HPCA3 and HPC5 in the PCR step yielded the hPurgamma-A coding sequence from the same testis mRNA preparation shown to yield hPurgamma-B (Fig. 4). Thus both isoforms of Purgamma mRNA are expressed in human testis. Sequencing of RT-PCR products confirms this. Given similarity in amplification, hPurgamma-B mRNA appears more abundant than hPurgamma-A in testis (Fig. 4). They are both transcribed primarily from sites located between F6 and F7 and less frequently from further upstream sites (data not shown), suggesting that they are under the same control of transcription initiation.
###end p 34
###begin p 35
By identifying Purgamma cDNA clones in the dbEST database, we found that hPurgamma-A was expressed in glioblastoma (BF245424), hPurgamma-B was expressed in fetal lung (AI338787), hPurgamma (unknown whether A or B) was expressed in hippocampus (BI550191) and in ovarian fibrotheoma (BF434119), mPurgamma-A was expressed in testis (AK015630), mPurgamma-B was expressed in blastocyst (AA793440) and in kidney (AI931378), and mPurgamma (unknown whether A or B) was expressed in skin (AA079942) and in mammary tumor (BE554692).
###end p 35
###begin p 36
###xml 326 327 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f7">7</xref>
###xml 1619 1620 1551 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f7">7</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 111 116 <span type="species:ncbi:9606">Human</span>
###xml 191 196 <span type="species:ncbi:9606">Human</span>
###xml 600 605 <span type="species:ncbi:9606">Human</span>
###xml 718 723 <span type="species:ncbi:9606">Human</span>
###xml 1141 1146 <span type="species:ncbi:9606">Human</span>
Human Purgamma mRNA expression was examined using commercially available cDNA panels from eight normal organs [Human Multiple Tissue cDNA (MTC) Panel I; Clontech] and eight tumor cell lines (Human Tumor MTC Panel; Clontech) by PCR amplification of hPurgamma-A and hPurgamma-B cDNAs from each of the 16 cDNA preparations (Fig. 7). When 34 PCR cycles were employed, no hPurgamma products were detected (not shown). While 46 cycles were necessary to detect hPurgamma PCR products in several normal tissues, 42 cycles were sufficient to detect hPurgamma mRNA expression in all of the tumor cells studed. Human Purgamma-A mRNA was expressed at different, but quite significant, levels in all of the eight tumor cell lines. Human Purgamma-B mRNA was detected in three of the tumor cell lines and its expression level was lower than that of the corresponding hPurgamma-A mRNA in each of these. In contrast, hPurgamma-A mRNA was only detected in three of the eight normal organs and no hPurgamma-B mRNA was detected in any of the eight normal organs. Thus far, hPurgamma-B mRNA has only been detected in certain fetal cells, testis and tumor cells. Human Purgamma-A mRNA, on the other hand, has been detected in a broader range of normal tissues and it may be expressed ubiquitously in tumor cells. The overall Purgamma mRNA expression levels in the eight normal organs were much lower than those in eight tumor cell lines. In particular, no hPurgamma-A or hPurgamma-B mRNA was detected in lung or pancreas, but hPurgamma-A mRNA was detected in the two lung carcinoma cell lines and the pancreas adenocarcinoma cell line (Fig. 7). These data suggest a potential relation between the up-regulation of Purgamma expression and tumorigenesis.
###end p 36
###begin title 37
DISCUSSION
###end title 37
###begin title 38
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
Overlapping, contrapodal promoters regulate initiation of transcription of PURG and WRN
###end title 38
###begin p 39
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 243 246 243 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c19">19</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c20">20</xref>
###xml 282 285 282 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c19">19</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c20">20</xref>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f2">2</xref>
###xml 835 838 823 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 884 888 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1470 1473 1458 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 1489 1491 1477 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c19">19</xref>
###xml 1522 1526 1510 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1622 1626 1610 1614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1864 1868 1852 1856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 1893 1896 1881 1884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SP1</italic>
###xml 1915 1918 1903 1906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUR</italic>
###xml 1952 1955 1940 1943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUR</italic>
###xml 2013 2017 2001 2005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 2157 2161 2141 2145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURA</italic>
###xml 2224 2226 2204 2206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c29">29</xref>
###xml 2304 2308 2280 2284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURA</italic>
###xml 2356 2360 2332 2336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 2361 2364 2337 2340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 2387 2390 2363 2366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 2522 2525 2494 2497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 2598 2602 2570 2574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 2618 2626 <span type="species:ncbi:9606">patients</span>
The contrapodal orientation of PURG and WRN raises questions regarding potential co-regulation of the two genes. For that reason we have defined the transcription unit and characterized the promoter for PURG. That has previously been done for WRN (19,20). It has been reported that WRN initiates transcription from multiple sites (19,20). Here 5'-RACE indicates that PURG also initiates from multiple sites (Fig. 2). In each case the 5'-most initiation sites lie within the transcription unit of the contraposed gene, suggesting that regulatory sequences may exist within the contraposed gene. The vast bulk, however, of transcripts for each gene initiate from closely spaced sites separated by approximately90 bp of intervening regulatory sequence. This separating regulatory region has previously been evaluated for transcription of WRN and evaluated in the present publication for PURG by us. In both cases the promoters have been evaluated in HeLa cells, in which both proteins have been observed to be expressed by immunohistochemistry (data not shown). We report that the intervening potential regulatory region functions in HeLa cells to highly promote transcription in both directions. In both cases the promoters are TATA-less and CAAT-less and contain many potentially bi-directional SP1 transactivational binding sites. Important distinctions, however, indicate that these two genes are not strictly co-regulated. Several of the SP1 sites deemed critical for WRN transcription (19) do not, when deleted, affect PURG transcription. While transcript levels for both genes are relatively high in testis and brain, PURG transcript levels in all normal tissues are low overall. Thus, while both genes may be housekeeping genes, there are important elements that regulate their expression levels in different tissues. The possibility of autoregulation of the PURG gene must be noted. All SP1 elements are also PUR elements and there are many more PUR elements in the common promoter region as well as in the PURG 5'-leader sequence. Thus, Purgamma or its related family members may bind to this region to influence transcription. Autoregulation of the PURA gene in this fashion by Puralpha has recently been described (29). In that study increasing levels of Puralpha reduced transcription from the PURA gene. Likewise, binding of Pur proteins to the PURG-WRN promoter could affect WRN transcription. It is conceivable in that case that expression of the Purgamma protein could directly regulate transcription of the WRN gene. It would thus be interesting to determine whether deregulation of PURG ever occurs in patients with Werner syndrome.
###end p 39
###begin p 40
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c30">30</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c43">43</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c35">35</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c42">42</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c39">39</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c40">40</xref>
###xml 896 900 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 901 904 901 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
It is now known that several human gene pairs are organized in contrapodal fashion with central, intervening regulatory regions (30-43). In most cases regulatory elements critical for transcription in each direction differ (35,42), whereas in certain cases bi-directional regulatory elements critical for both genes have been reported (39,40). Even in those cases, however, additional regulatory elements differed between the two genes. What evolutionary benefit is there for the presence of head-to-head overlapping promoters if transcription of the two contraposed genes is not co-regulated? One possibility is that two such genes might not be normally co-regulated, but that in response to certain cellular signals it would be beneficial to simultaneously up- or down-regulate both of them. All of the promoters referenced above are highly G+C-rich and may be targets for DNA methylation. The PURG-WRN promoter region is also extremely G+C-rich. It will be interesting to determine whether, and how, DNA methylation affects expression of these genes.
###end p 40
###begin p 41
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c44">44</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c45">45</xref>
###xml 456 460 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 461 464 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 565 569 565 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f7">7</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 559 564 <span type="species:ncbi:9606">Human</span>
Results from scanning a panel of human tissues reveal that WRN mRNA exists in all 24 tissues examined (data not shown), suggesting that it is a housekeeping gene, in keeping with previous speculation. Housekeeping genes generally have a CpG island of some 200-1000 bp spanning the promoter region, frequently extending into the first exon (44). These promoters are not only rich in G/C, but are also characterized by a CpG/GpC ratio that is >0.6 (45). The PURG-WRN promoter region has these features. Similarly, the two genes each have no TATA or CAAT boxes. Human PURG may also be a housekeeping gene, but, if so, its levels must be quite low in certain cells or under certain conditions, as indicated by the expression levels in Figure 7.
###end p 41
###begin p 42
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hPURG</italic>
###xml 190 193 190 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c27">27</xref>
There are several potential ATG translation start sites in the hPURG 5'-UTR prior to the one at which translation actually initiates. This is unusual among gene 5'-UTRs. Note, however, that WRN also has two ATG codons upstream of its translation start site. In each case, for either gene, the upstream ATGs do not have favorable surrounding consensus sequences for translation initiation (27) and they are followed shortly thereafter by stop codons.
###end p 42
###begin title 43
Purgamma protein isoforms relate structural features of Pur family members to neoplasia
###end title 43
###begin p 44
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f7">7</xref>
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 133 139 133 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 611 612 604 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c1">1</xref>
###xml 613 615 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c13">13</xref>
###xml 675 677 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c17">17</xref>
###xml 688 690 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c46">46</xref>
###xml 1245 1247 1211 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c15">15</xref>
###xml 1431 1433 1389 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c47">47</xref>
###xml 1298 1303 <span type="species:ncbi:9606">human</span>
Figure 7 reveals that the PURG gene is highly expressed in many tumor cell lines. In cells in which the PURG-B form is expressed the PURG-A form is also present at high levels. The results suggest that enhanced expression of PURG may be regulated at the level of initiation of transcription. It remains to be determined whether or not increased PURG transcription is coupled to increased cell proliferation. The present results likely extend the Pur family to comprise at least four distinct proteins. Puralpha and Purbeta are both single-stranded DNA-binding proteins that bind specifically to repeats of GGN (1,13). The repeat region of Puralpha is essential for both DNA (17) and RNA (46) binding. Given the high degree of homology of Purgamma repeats to those of the other Pur proteins, it is likely that the Purgamma DNA- and RNA-binding properties are similar, although this remains to be demonstrated. Outside the repeat motifs there are important distinctions between Pur proteins. Both the Purgamma-A and -B forms contain the sequence QGSRRRQKHS, a potential nuclear localization signal absent from Puralpha and Purbeta. Thus, while Puralpha access to, and exclusion from, the nucleus is highly regulated by multiple amino acid motifs (15), Purgamma may be more stably directed there. All human Pur proteins contain a variation of the Puralpha psycho motif, located C-terminal to the repeats and implicated in Rb binding (47). Part of this motif in Puralpha includes a potential casein kinase II Ser phosphorylation site in the form FCKYSEEM. This differs in the hPur family members as follows:
###end p 44
###begin p 45
FCKYSEEM Puralpha
###end p 45
###begin p 46
FCRYADEM Purbeta
###end p 46
###begin p 47
FIKYEEEM Purgamma-A
###end p 47
###begin p 48
###xml 256 258 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c17">17</xref>
###xml 848 852 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 932 933 898 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f7">7</xref>
In Puralpha a negative charge may be conferred on the S by phosphorylation. In Purbeta this is not possible at the A. In Purgamma-A the E residue specifies a permanent negative charge. Given that this is reportedly in a protein-protein interaction region (17), this change could be functionally significant, although further work must substantiate this. It is most notable that Purgamma-B completely lacks the psycho motif. Thus, while Rb binding may be altered among Puralpha, Purbeta and Purgamma-A, it may not be possible at all for Purgamma-B. In this regard, Purgamma-B may be a dominant-negative form of Pur protein, since it contains the conserved DNA- and RNA-binding repeats. Its preferential expression in certain tumor cells could conceivably be related to the propensity of such cells to evade Rb-controlled cell cycle checkpoints. The PURG B-form is expressed in colon adenocarcinoma and prostatic adenocarcinoma (Fig. 7). It would be interesting to know whether such expression occurs early or late in the progression to neoplasia.
###end p 48
###begin title 49
Novel aspects of transcription termination/polyadenylation control expression of hPurgamma isoforms
###end title 49
###begin p 50
###xml 416 420 412 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 485 491 481 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 496 502 492 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 715 721 711 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 726 732 722 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 838 840 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c48">48</xref>
###xml 1056 1058 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf356c49">49</xref>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
###xml 743 748 <span type="species:ncbi:4932">yeast</span>
A novel mechanism involving differential termination/polyadenylation controls the expression of mRNAs for the two Purgamma isoforms in both human and mouse. Little is known about the control of transcriptional termination by RNA polymerase II in higher eukaryotes, but it is widely held that termination occurs 3', and quite proximal, to a polyadenylation signal. The precise mechanism by which synthesis of the two PURG mRNAs is regulated are not known, but one observation is clear: PURG-A and PURG-B transcripts are polyadenylated at different sites which are greatly distant in the genome. Therefore, it can be concluded that some aspect of termination/polyadenylation differentially controls the expression of PURG-A and PURG-B mRNAs. In yeast certain proteins controlling termination and those controlling polyadenylation interact (48). In higher eukaryotes it has been reported that specific G-rich sequences near to, and downstream of, a polyadenylation signal induce transcriptional pausing, leading to the cleavage that precedes polyadenylation (49). This tight coupling of termination and polyadenylation strongly mitigates against a termination site >30 kb 3' to a polyadenylation signal. Therefore, it is likely that a factor, or factors, controlling coupled termination/polyadenylation is responsible for differential expression of the two Purgamma isoforms.
###end p 50
###begin p 51
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hPURG-B</italic>
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mPURG-B</italic>
###xml 206 213 206 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hPURG-A</italic>
###xml 232 238 232 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 374 380 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 525 531 513 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
There is a canonical polyadenylation signal AATAAA located 14 bp upstream of the hPURG-B poly(A) site. In mouse this signal is 15 bp upstream of the mPURG-B poly(A) site. There is no such sequence near the hPURG-A poly(A) site, yet PURG-A comprises the bulk of the expressed PURG in most cells. There are several sequences similar to AATAAA in the vicinity of the 3'-end of PURG-A and it is conceivable that a cryptic polyadenylation signal is employed. There is also an ATTAAA element approximately300 nt from the 3'-end of PURG-A and it is also possible that it is functional.
###end p 51
###begin p 52
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 132 138 132 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf356f7">7</xref>
The detection of PURG-B expression primarily in tumor cells raises the possibility that a polyadenylation signal near the 3'-end of PURG-A could be mutated, thus allowing transcription to proceed through the PURG-B exon. We cannot currently state that this never happens, but, thus far, sequencing of the 3'-UTR from mRNAs from several tumor tissues and lines has not revealed any mutations or deletions. Thus, if PURG transcription is aberrant in cancer, as suggested in Figure 7, it is likely to be due to alterations in the termination/polyadenylation mechanism.
###end p 52
###begin title 53
Figures and Tables
###end title 53
###begin p 54
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 278 281 278 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 51 56 <span type="species:ncbi:9606">human</span>
 Genomic organization of the PURG and WRN genes at human chromosome band 8p11-12. Arrows represent the direction of gene transcription. Boxes represent exons of PURG and WRN. Coding regions of the two genes are shown as dark boxes. The most upstream transcription start site of WRN defined by Yamabe et al. (19) is designated position +1. The positions of WRN exons in this number system were calculated from the genomic sequence, GenBank accession no. AF181896. The 5'-UTR of PURG is not shown here.
###end p 54
###begin p 55
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 572 573 572 573 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 854 855 854 855 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 872 876 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 577 582 <span type="species:ncbi:9606">human</span>
 Identification of transcription start sites of human PURG. (A) Schematic diagram of genomic region around the 5'-ends of PURG and WRN and positions of primers used in RT-PCR and 5'-RACE. The numerical system used here is the same as in Figure 1. The region with 89% G+C encompasses positions -755 to -956. The position of each primer is shown as follows: R1, -1110 to -1085; R2, -390 to -366; R3, -363 to -339; R4, -325 to -304; F1, -905 to -925; F2, -716 to -740; F3, -562 to -583; F4, -411 to -431; F5, -261 to -285; F6, -176 to -199; F7, +3 to -20; F8, +257 to +233. (B) A human testis mRNA preparation (Clontech) was reverse transcribed with reverse primer R1 (left) or R3 (right) and was then PCR amplified with R1 and F5 (left) or R3 and F6, F7 or F8 (right). For negative controls there was no incubation time in the reverse transcription step. (C) The 5'-RACE of PURG was performed as described in Materials and Methods. Nested primers R2, R3 and R4 were used in the reverse transcription, first PCR and second PCR, respectively. The second PCR products were separated in a 1.2% agarose gel.
###end p 55
###begin p 56
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 41 42 41 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG</italic>
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WRN</italic>
###xml 143 146 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 286 287 286 287 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 584 588 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
 Characterization of the PURG promoter. (A) The PURG and WRN major transcription start sites are indicated by arrowed lines. Several potential cis-regulatory elements described in the text are indicated by open boxes. The numerical system used here is the same as in Figures 1 and 2A. (B) Promoter activities of various DNA fragments were measured as described in Materials and Methods. The arrows with numbers at their ends indicate the locations of various DNA fragments and the directions in which they are cloned into pGL3-Basic (Promega). Plasmid pGL3-Control (Promega) contains SV40 promoter and enhancer sequences that drive strong expression of the firefly luciferase gene, while plasmid pGL3-Basic lacks eukaryotic promoter and enhancer sequences. Numbers presented are relative light emission from the luciferase reaction, detected as described in Materials and Methods. Emission due to plasmid pGL3-Basic promoter activity is assigned the value 1.0.
###end p 56
###begin p 57
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 64 69 <span type="species:ncbi:9606">Human</span>
###xml 105 110 <span type="species:ncbi:9606">human</span>
 Expression of Purgamma-A and Purgamma-B mRNAs in human testis. Human Purgamma-A or Purgamma-B mRNA in a human testis mRNA preparation (Clontech) was reverse transcribed with either primer HPCA3 or HPCB3 and was then PCR amplified with either primers HPCA3 and HPC5 or primers HPCB3 and HPC5. For negative controls there was no incubation time in the reverse transcription step.
###end p 57
###begin p 58
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
 Comparison of the C-termini of human and mouse Purgamma-A and Purgamma-B. Residues that are different in human and mouse Purgamma proteins are underlined. Dashed lines indicate the position of the spliced-out intron in Purgamma-B mRNA. Asterisks represent the stop codons for Purgamma-A and Purgamma-B.
###end p 58
###begin p 59
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 85 91 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 155 161 155 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 446 452 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 457 463 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 534 540 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-A</italic>
###xml 545 551 537 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PURG-B</italic>
###xml 22 27 <span type="species:ncbi:9606">human</span>
 Genomic structure of human PURG-A and PURG-B. The open box represents the 5'-UTR of PURG-A and PURG-B. The gray boxes represent the 3'-UTRs of PURG-A and PURG-B. The coding sequences (CS) of Purgamma-A and Purgamma-B are represented by stippled boxes. DNA sequences at the exon-intron boundaries are shown, with exon sequences in upper case letters and intron sequences in lower case letters. Waved arrows indicate the polyadenylation sites for PURG-A and PURG-B mRNAs. T and T' indicate the regions of transcription termination for PURG-A and PURG-B, respectively. The pitched lines indicate the splicing that generates Purgamma-B mRNA.
###end p 59
###begin p 60
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 93 98 <span type="species:ncbi:9606">Human</span>
###xml 127 132 <span type="species:ncbi:9606">Human</span>
 Expression of human Purgamma-A and Purgamma-B mRNAs in normal tissues and tumor cell lines. Human MTC Panel I (lanes 1-8) and Human Tumor MTC Panel (lanes 9-16) were obtained from Clontech Laboratories. Purgamma-A and Purgamma-B cDNAs were PCR amplified with primer sets HPC5M/HPCA3 and HPC5M/HPCB3, respectively. The sizes of the products are 356 and 355 bp, respectively. G3PDH expression in all samples was examined as an internal control. The 16 samples are as follows: lane 1, heart; lane 2, brain; lane 3, placenta; lane 4, lung; lane 5, liver; lane 6, skeletal muscle; lane 7, kidney; lane 8, pancreas; lane 9, breast carcinoma GI-101; lanes 10 and 11, colon adenocarcinoma CX-1 and GI-112; lanes 12 and13, lung carcinoma LX-1 and GI-117; lane 14, pancreatic adenocarcinoma GI-103; lane 15, prostatic adenocarcinoma PC3; lane 16, ovarian carcinoma GI-102.
###end p 60
###begin title 61
ACKNOWLEDGEMENTS
###end title 61
###begin p 62
We thank Yayoi Kinoshita for excellent technical assistance. This work was supported by grants from the NCI and NINDS to E.M.J.
###end p 62
###begin title 63
REFERENCES
###end title 63

